| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. (CTNM) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 3 sells. CTNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 249.2K | $3.82M | - | |
| Other | 206.4K | $3.17M | - | |
| CFO | 192.0K | $2.95M | - | |
| Other | 135.2K | $2.08M | -25 | |
| CEO | 19.7K | $302.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 1,010 | $16.02 | $16,177.37 | -0.6% | -50.6% | -30.3% | |
| Nov 18, 2024 | Lorrain Daniel S.68 | Chief Scientific Officer | Sell | 6,190 | $16.38 | $101,420.77 | -1.8% | -53.5% | -27.3% |